• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Top Five Global Retail Drug Companies: Performance, Strategies and Competitive Analysis Product Image

Top Five Global Retail Drug Companies: Performance, Strategies and Competitive Analysis

  • Published: November 2012
  • Region: Global
  • Lucintel

The global retail drug industry has grown steadily over the last five years and is expected to reach approximately US $1,420 billion in 2017 with a CAGR of 3.6% over the next five years. Direct mail advertising, television and print media advertising, telemarketing, Internet advertising and social media, as well as bundled product and service strategies, are expected to drive industry growth.

The report provides detailed insight into the performance of the top five global retail drug companies across the world. The analysis highlights the companies that are performing the best among the peer group, and in which areas, and therefore clarifies leading performance standards and the strengths and weaknesses of companies covered.

The retail drug industry is highly diversified and includes pharmacies and drug stores, cosmetics, beauty supplies, and perfume stores, optical goods stores, other health, and personal care stores. In this study, Lucintel thoroughly profiles the following five companies with detailed competitive assessments:

- CVS Caremark
- Rite Aid
- Target Corp.
- Walgreens
- Walmart

Lucintel’s research indicates that the Asia Pacific READ MORE >

1. Executive Summary
2. Market Definition and Scope
3. Market Opportunity
4. Competitive Benchmarking (Financial and Market)
Company Profile on Following Parameters
Company Overview
Benchmarking (Financial & Market)
SWOT Analysis
Product Positioning
Marketing Strategy and Tactics
Corporate Strategy
5. Company Profile on CVS Caremark
6. Company Profile on Rite Aid
7. Company Profile on Target Corp.
8. Company Profile on Walgreens
9. Company Profile on Walmart

List of Figures and Charts

CHAPTER 3. Market Opportunity
Figure 3.1: Supply chain for retail drug market
Figure 3.2: Global retail drug industry annual trend 2006-2011 (US $B)
Figure 3.3: Global retail drug industry regional trend 2006-2011 (US $B)
Figure 3.4: Global retail drug industry regional trend 2006-2011 (%)
Figure 3.5: Global retail drug industry segment trend 2006-2011 (US $B)
Figure 3.6: Global retail drug industry segment trend 2006-2011 (%)
Figure 3.7: Global retail drug industry opportunity by region
Figure 3.8: Global retail drug industry opportunity by segment

CHAPTER 4. Competitive Benchmarking (Financial and Market)
Figure 4.1: Top five retail drug companies – financial benchmarking
Figure 4.2: Global top five retail drug companies gross profit and net profit analysis – 2011
Figure 4.3: Financial analysis – growth leadership quadrant (2011)
Figure 4.4: Market share of top players 2006
Figure 4.5: Market share of top players 2011
Figure 4.6: 2006 Market share analysis 2011
Figure 4.7: 2011 Market share analysis 2011
Figure 4.8: Global market share analysis 2011
Figure 4.9: Global market fragmentation 2011
Figure 4.10: Market value North America: (US $B)
Figure 4.11: Market value Europe: (US $B)
Figure 4.12: Market value Asia Pacific: (US $B)
Figure 4.13: Market value Row: (US $B)
Figure 4.14: Regional revenue evaluation 2011(US $B)
Figure 4.15: Regional revenue evaluation 2011(%)
Figure 4.16: North American revenue trend for top players 2007-2011 (US $B)
Figure 4.17: Europe revenue trend for top players 2007-2011 (US $B)
Figure 4.18: Asia Pacific revenue trend for top players 2007-2011 (US $B)
Figure 4.19: Row revenue trend for top players 2007-2011 (US $B)
Figure 4.20: Lucintel triad - top five major players

CHAPTER 5. Company Profile of CVS Caremark
Figure 5.1: CVS Caremark’s revenue by business structure 2011
Figure 5.2: Lucintel Triad – CVS Caremark’s
Figure 5.3: Financial benchmarking CVS Caremark’s against top three and top five industry players’ average
Figure 5.4: Financial benchmarking of CVS Caremark’s against top five best
Figure 5.5: Global industry revenue trend Vs CVS Caremark’s (2007-2011) in US $B
Figure 5.6: Global market share trend for CVS Caremark’s (2007-2011) in (%)
Figure 5.7: North American industry revenue trend Vs CVS Caremark’s 2007-2011 in (US $B)
Figure 5.8: European industry revenue trend Vs CVS Caremark’s 2007-2011 in (US $B)
Figure 5.9: APAC industry revenue trend Vs CVS Caremark’s 2007-2011 in (US $B)
Figure 5.10: ROW industry revenue trend Vs CVS Caremark’s 2007-2011 in (US $B)
Figure 5.11: North American market share trend Vs CVS Caremark’s 2007-2011 in (%)
Figure 5.12: European market share trend Vs CVS Caremark’s 2007-2011 in (%)
Figure 5.13: APAC market share trend Vs CVS Caremark’s 2007-2011 in (%)
Figure 5.14: ROW market share trend Vs CVS Caremark’s 2007-2011 in (%)
Figure 5.15: CVS Caremark’s productivity: 2007-2011 in (US $B)
Figure 5.16: CVS Caremark’s fixed asset value: 2007-2011 in (US $B)
Figure 5.17: Strategic execution

CHAPTER 6. Company Profile of Rite Aid
Figure 6.1: Rite Aid revenue by business structure 2011
Figure 6.2: Lucintel triad - Rite Aid
Figure 6.3: Financial benchmarking of Rite Aid against top three and top five industry players’ average
Figure 6.4: Financial benchmarking of Rite Aid against Top five best
Figure 6.5: Global industry revenue trend Vs Rite Aid (2007-2011) in (US $B)
Figure 6.6: Global market share trend for Rite Aid. (2007-2011) in (%)
Figure 6.7: North American industry revenue trend Vs Rite Aid. 2007-2011 in (US $B)
Figure 6.8: European industry revenue trend Vs Rite Aid. 2007-2011 in (US $B)
Figure 6.9: APAC industry revenue trend Vs Rite Aid. 2007-2011 in (US $B)
Figure 6.10: ROW industry revenue trend Vs Rite Aid 2007-2011 in (US $B)
Figure 6.11: North American market share trend Vs Rite Aid. 2007-2011 in (%)
Figure 6.12: European market share trend Vs Rite Aid. 2007-2011 in (%)
Figure 6.13: APAC market share trend Vs Rite Aid. 2007-2011 in (%)
Figure 6.14: ROW market share trend Vs Rite Aid. 2007-2011 in (%)
Figure 6.15: Rite Aid productivity: 2007-2011 in (US $B)
Figure 6.16: Rite Aid fixed asset value: 2007-2011 in (US $B)
Figure 6.17: Strategic execution

CHAPTER 7. Company Profile of Target Corp.
Figure 7.1: Target Corp. revenue by business structure 2011
Figure 7.2: Lucintel triad – Target Corp.
Figure 7.3: Financial benchmarking of Target Corp. against top three and top five industry players’ average
Figure 7.4: Financial benchmarking of Target Corp. against Top five best
Figure 7.5: Global industry revenue trend Vs Target Corp. (2007-2011) in (US $B)
Figure 7.6: Global market share trend for Target Corp. (2007-2011) in (%)
Figure 7.7: North American industry revenue trend Vs Target Corp. (2007-2011) in (US$B)
Figure 7.8: European industry revenue trend Vs Target Corp. (2007-2011) in (US $B)
Figure 7.9: APAC industry revenue trend Vs Target Corp. (2007-2011) in (US $B)
Figure 7.10: ROW industry revenue trend Vs Target Corp. (2007-2011) in (US $B)
Figure 7.11: North American market share trend Vs Target Corp. (2007-2011) in (%)
Figure 7.12: European market share trend Vs Target Corp. (2007-2011) in (%)
Figure 7.13: APAC market share trend Vs Target Corp. (2007-2011) in (%)
Figure 7.14: ROW market share trend Vs Target Corp. (2007-2011) in (%)
Figure 7.15: Target Corp. productivity: 2007-2011 in (US $B)
Figure 7.16: Target Corp. fixed asset value: 2007-2011 in (US $B)
Figure 7.17: Strategic execution

CHAPTER 8. Company Profile of Walgreens
Figure 8.1: Walgreens revenue by business structure 2011
Figure 8.2: Lucintel triad – Walgreens
Figure 8.3: Financial benchmarking of Walgreens against top three and top five industry players’ average
Figure 8.4: Financial benchmarking of Walgreens against Top five best
Figure 8.5: Global industry revenue trend Vs Walgreens (2007-2011) in (US $B)
Figure 8.6: Global market share trend for Walgreens (2007-2011) in (%)
Figure 8.7: North American industry revenue trend Vs Walgreens (2007-2011) in (US $B)
Figure 8.8: European industry revenue trend Vs Walgreens (2007-2011) in (US $B)
Figure 8.9: APAC industry revenue trend Vs Walgreens (2007-2011) in (US $B)
Figure 8.10: ROW industry revenue trend Vs Walgreens (2007-2011) in (US $B)
Figure 8.11: North American market share trend Vs Walgreens (2007-2011) in (%)
Figure 8.12: European market share trend Vs Walgreens (2007-2011) in (%)
Figure 8.13: APAC market share trend Vs Walgreens (2007-2011) in (%)
Figure 8.14: ROW market share trend Vs Walgreens (2007-2011) in (%)
Figure 8.15: Walgreens productivity: 2007-2011 in (US $B)
Figure 8.16: Walgreens fixed asset value: 2007-2011 in (US $B)
Figure 8.17: Strategic execution

CHAPTER 9. Company Profile of Walmart
Figure 9.1: Walmart revenue by business structure 2011
Figure 9.2: Lucintel triad – Walmart
Figure 9.3: Financial benchmarking of Walmart against top three and top five industry players’ average
Figure 9.4: Financial benchmarking of Walmart against Top five best
Figure 9.5: Global industry revenue trend Vs Walmart (2007-2011) in (US $B)
Figure 9.6: Global market share trend for Walmart (2007-2011) in (%)
Figure 9.7: North American industry revenue trend Vs Walmart (2007-2011) in (US $B)
Figure 9.8: European industry revenue trend Vs Walmart (2007-2011) in (US $B)
Figure 9.9: APAC industry revenue trend Vs Walmart (2007-2011) in (US $B)
Figure 9.10: ROW industry revenue trend Vs Walmart (2007-2011) in (US $B)
Figure 9.11: North American market share trend Vs Walmart (2007-2011) in (%)
Figure 9.12: European market share trend Vs Walmart (2007-2011) in (%)
Figure 9.13: APAC market share trend Vs Walmart (2007-2011) in (%)
Figure 9.14: ROW market share trend Vs Walmart (2007-2011) in (%)
Figure 9.15: Walmart productivity 2007-2011 in (US $B)
Figure 9.16: Walmart fixed asset value 2006-2010 in (US $B)
Figure 9.17: Strategic execution

List of Tables

CHAPTER 3. Market Opportunity
Table 3.1: Industry parameters of global retail drug industry
Table 3.2: Relative market attractiveness by region
Table 3.3: Regional revenue growth rate
Table 3.4: Segment revenue growth rate

CHAPTER 4. Competitive Benchmarking (Financial and Market)
Table 4.1: Financial benchmarking of top five global retail drug companies
Table 4.2: Key financial parameters for top five pesticide companies
Table 4.3: Regional revenue (US $B)
Table 4.4: Regional revenue (%)
Table 4.5: Competitors based on markets served
Table 4.6: Lucintel triad - Top five major players

CHAPTER 5. Company Profile of CVS Caremark’s
Table 5.1: Market served CVS Caremark’s
Table 5.2: Lucintel triad – CVS Caremark’s
Table 5.3: Financial Benchmarking of CVS Caremark’s against best and against Top three and Top five industry players’ average
Table 5.4: Strategic execution – product positioning by segment
Table 5.5: Strategic execution – perceived customer value / quality
Table 5.6: Strategic execution – promotion / communications
Table 5.7: Strategic execution – product distribution by region

CHAPTER 6. Company Profile of Rite Aid
Table 6.1: Market served – Rite Aid
Table 6.2: Lucintel triad – Rite Aid
Table 6.3: Financial benchmarking of Rite Aid. against best and against Top three and Top five industry players’ average
Table 6.4: Strategic execution – product positioning by segment
Table 6.5: Strategic execution – perceived customer value / quality
Table 6.6: Strategic execution – promotion / communications
Table 6.7: Strategic execution – product distribution by region

CHAPTER 7. Company Profile of Target Corp.
Table 7.1: Market served – Target Corp.
Table 7.2: Lucintel triad – Target Corp.
Table 7.3: Financial benchmarking of Target Corp. against best and against Top three and Top five industry players’ average
Table 7.4: Strategic execution – product positioning by segment
Table 7.5: Strategic execution – perceived customer value / quality
Table 7.6: Strategic execution – promotion / communications
Table 7.7: Strategic execution – product distribution by region

CHAPTER 8. Company Profile of Walgreens
Table 8.1: Market served – Walgreens.
Table 8.2: Lucintel triad – Walgreens.
Table 8.3: Financial Benchmarking of Walgreens against best and against Top three and top five industry players’ average
Table 8.4: Strategic execution – product positioning by segment
Table 8.5: Strategic execution – perceived customer value / quality
Table 8.6: Strategic execution – promotion / communications
Table 8.7: Strategic execution – product distribution by region

CHAPTER 9. Company Profile of Walmart
Table 9.1: Markets Served – Walmart
Table 9.2: Lucintel triad – Walmart
Table 9.3: Financial Benchmarking of Walmart against best and against Top three and top five industry players’ average
Table 9.4: Strategic execution – product positioning by segment
Table 9.5: Strategic execution – perceived customer value / quality
Table 9.6: Strategic execution – promotion / communications
Table 9.7: Strategic execution – product distribution by region

Note: Product cover images may vary from those shown

RELATED PRODUCTS